Nuveen LLC Acquires New Stake in Genpact Limited $G

Nuveen LLC acquired a new stake in Genpact Limited (NYSE:G - Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 494,397 shares of the business services provider's stock, valued at approximately $24,908,000. Nuveen LLC owned about 0.28% of Genpact at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Envestnet Portfolio Solutions Inc. lifted its stake in Genpact by 59.2% in the first quarter. Envestnet Portfolio Solutions Inc. now owns 10,355 shares of the business services provider's stock valued at $522,000 after buying an additional 3,849 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its stake in Genpact by 20.6% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 9,650 shares of the business services provider's stock valued at $486,000 after buying an additional 1,651 shares during the last quarter. GAMMA Investing LLC lifted its stake in Genpact by 88.0% in the first quarter. GAMMA Investing LLC now owns 9,744 shares of the business services provider's stock valued at $491,000 after buying an additional 4,561 shares during the last quarter. 111 Capital purchased a new stake in Genpact in the fourth quarter valued at approximately $301,000. Finally, Assenagon Asset Management S.A. purchased a new stake in Genpact in the first quarter valued at approximately $2,396,000. Hedge funds and other institutional investors own 96.03% of the company's stock.

Genpact Price Performance

G stock traded up $1.16 on Friday, reaching $45.68. 353,089 shares of the company's stock were exchanged, compared to its average volume of 1,617,004. The stock has a fifty day moving average of $44.01 and a 200-day moving average of $46.89. Genpact Limited has a twelve month low of $37.82 and a twelve month high of $56.76. The firm has a market cap of $7.96 billion, a PE ratio of 15.18, a P/E/G ratio of 1.51 and a beta of 0.92. The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 0.32.

Genpact (NYSE:G - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The business services provider reported $0.88 earnings per share for the quarter, topping analysts' consensus estimates of $0.85 by $0.03. The firm had revenue of $1.25 billion for the quarter, compared to analyst estimates of $1.23 billion. Genpact had a return on equity of 22.15% and a net margin of 10.92%.Genpact's quarterly revenue was up 6.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.79 earnings per share. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. As a group, equities analysts predict that Genpact Limited will post 3.21 EPS for the current fiscal year.

Genpact Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Thursday, September 11th will be issued a $0.17 dividend. The ex-dividend date of this dividend is Thursday, September 11th. This represents a $0.68 annualized dividend and a yield of 1.5%. Genpact's dividend payout ratio is 22.59%.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. Wall Street Zen upgraded Genpact from a "buy" rating to a "strong-buy" rating in a research note on Friday, June 6th. Robert W. Baird cut their price target on Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research note on Thursday, May 8th. Needham & Company LLC upped their price target on Genpact from $50.00 to $53.00 and gave the stock a "buy" rating in a research note on Friday, August 8th. Deutsche Bank Aktiengesellschaft assumed coverage on Genpact in a research note on Thursday, July 17th. They set a "hold" rating and a $47.00 price target for the company. Finally, JPMorgan Chase & Co. cut their price target on Genpact from $55.00 to $50.00 and set a "neutral" rating for the company in a research note on Wednesday. Three equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $52.29.

Genpact Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.